» Articles » PMID: 19190781

Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia

Abstract

Background: Antibiotics are a major tool in the WHO's trachoma control program. Even a single mass distribution reduces the prevalence of the ocular chlamydia that causes trachoma. Unfortunately, infection returns after a single treatment, at least in severely affected areas. Here, we test whether additional scheduled treatments further reduce infection, and whether infection returns after distributions are discontinued.

Methods: Sixteen communities in Ethiopia were randomly selected. Ocular chlamydial infection in 1- to 5-year-old children was monitored over four biannual azithromycin distributions and for 24 months after the last treatment.

Findings: The average prevalence of infection in 1- to 5-year-old children was reduced from 63.5% pre-treatment to 11.5% six months after the first distribution (P<0.0001). It further decreased to 2.6% six months after the fourth and final treatment (P = 0.0004). In the next 18 months, infection returned to 25.2%, a significant increase from six months after the last treatment (P = 0.008), but still far lower than baseline (P<0.0001). Although the prevalence of infection in any particular village fluctuated, the mean prevalence of the 16 villages steadily decreased with each treatment and steadily returned after treatments were discontinued.

Conclusion: In some of the most severely affected communities ever studied, we demonstrate that repeated mass oral azithromycin distributions progressively reduce ocular chlamydial infection in a community, as long as these distributions are given frequently enough and at a high enough coverage. However, infection returns into the communities after the last treatment. Sustainable changes or complete local elimination of infection will be necessary.

Trial Registration: ClinicalTrials.gov NCT00221364.

Citing Articles

Cluster randomised controlled trial of double-dose azithromycin mass drug administration, facial cleanliness and fly control measures for trachoma control in Oromia, Ethiopia: the stronger SAFE trial protocol.

Last A, Shafi Abdurahman O, Greenland K, Robinson A, Collin C, Czerniewska A BMJ Open. 2024; 14(12):e084478.

PMID: 39719287 PMC: 11751794. DOI: 10.1136/bmjopen-2024-084478.


Comparison of metrics for assessing face washing behaviour for trachoma control.

Greenland K, Collin C, Etu E, Guye M, Hika D, Macleod D PLoS Negl Trop Dis. 2024; 18(8):e0012399.

PMID: 39141680 PMC: 11346966. DOI: 10.1371/journal.pntd.0012399.


Eliminating Trachoma in Africa: The Importance of Environmental Interventions.

Ageed A, Khan M Cureus. 2024; 16(1):e52358.

PMID: 38234389 PMC: 10792353. DOI: 10.7759/cureus.52358.


Trachoma risk factors in Oromia Region, Ethiopia.

Shafi Abdurahman O, Last A, Macleod D, Habtamu E, Versteeg B, Dumessa G PLoS Negl Trop Dis. 2023; 17(11):e0011679.

PMID: 37934731 PMC: 10629622. DOI: 10.1371/journal.pntd.0011679.


Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys.

Goodhew E, Taoaba R, Harding-Esch E, Gwyn S, Bakhtiari A, Butcher R PLoS Negl Trop Dis. 2023; 17(7):e0011441.

PMID: 37418501 PMC: 10355439. DOI: 10.1371/journal.pntd.0011441.


References
1.
Lietman T, Porco T, Dawson C, Blower S . Global elimination of trachoma: how frequently should we administer mass chemotherapy?. Nat Med. 1999; 5(5):572-6. DOI: 10.1038/8451. View

2.
Burton M, Holland M, Makalo P, Aryee E, Alexander N, Sillah A . Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005; 365(9467):1321-8. DOI: 10.1016/S0140-6736(05)61029-X. View

3.
Taylor H . Towards the global elimination of trachoma. Nat Med. 1999; 5(5):492-3. DOI: 10.1038/8376. View

4.
West S, Emerson P, Mkocha H, McHiwa W, Munoz B, Bailey R . Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. Lancet. 2006; 368(9535):596-600. DOI: 10.1016/S0140-6736(06)69203-9. View

5.
Peeling R, Toye B, Jessamine P, Gemmill I . Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect. 1998; 74(1):66-70. PMC: 1758079. DOI: 10.1136/sti.74.1.66. View